Terrance D. Barrett

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

Vlado Perkovic, Dick de Zeeuw, Kenneth W. Mahaffey et al. · The Lancet Diabetes & Endocrinology · 2018 · 632 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +12

Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus

Karin Rådholm, Gemma A. Figtree, Vlado Perkovic et al. · Circulation · 2018 · 469 citations · Full text

Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries

James K. Hennan, Jinbao Huang, Terrance D. Barrett et al. · Circulation · 2001 · 162 citations

RETRACTED: Obestatin reduces food intake and suppresses body weight gain in rodents

Guy Lagaud, Andy Young, Auzon Acena et al. · Biochemical and Biophysical Research Communications · 2007 · 117 citations

Obesity, Metabolic Syndrome, Nutrition +13

C-Reactive-Protein-Associated Increase in Myocardial Infarct Size After Ischemia/Reperfusion

Terrance D. Barrett, James K. Hennan, Rory M. Marks et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 92 citations